CSIMarket Company Name, Ticker, Competitors, else..


Bright Minds Biosciences Inc   (NASDAQ: DRUG)
Other Ticker:  
 

Bright Minds Biosciences Inc

DRUG's Fundamental analysis



Bright Minds Biosciences Inc 's sales fell in IV. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.76 %

Bright Minds Biosciences Inc net loss decreased from $-11 millions, to $-6 millions in IV. Quarter 2023,

• More on DRUG's Growth


Bright Minds Biosciences Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 14.57 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.


• More on DRUG's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.36

Bright Minds Biosciences Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 14.57 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.

Bright Minds Biosciences Inc Price to Book Ratio is at 25.67 lower than Industry Avg. of 91.79. and higher than S&P 500 Avg. of 0.01

• More on DRUG's Valuation

•  Market Capitalization (Millions $) 130
•  Shares Outstanding (Millions) 4
•  Employees 57
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -6
•  Cash Flow (TTM) (Millions $) 9
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 1.36

•  Market Capitalization (Millions $) 130
•  Shares Outstanding (Millions) 4
•  Employees 57
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -6
•  Cash Flow (TTM) (Millions $) 9
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 24.26
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.04
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com